Would it be a good idea to have tariffs on pharmaceuticals? In this episode: a conversation about the rationales for tariffs as well as potential downsides—like higher drug prices—and what could really help with supply and pricing issues.
Dr. Mariana Socal studies the pharmaceutical market and is an associate professor in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health.
Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland’s Health Department.
Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains—Johns Hopkins Carey Business School
Trump’s pharmaceutical tariffs could raise costs for patients, worsen drug shortages—NBC Los Angeles
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Here's our RSS feed
Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
